Metreleptin and Metformin Use in an Infant With Congenital Generalized Lipodystrophy Secondary to AGPAT2 Mutation

Background: Congenital generalized lipodystrophy (CGL) is a rare inherited disease characterized by widespread loss of subcutaneous fat and severe metabolic abnormalities. Metreleptin, a synthetic analog of leptin, is a treatment modality that has been shown to decrease fasting triglycerides, fastin...

Descripción completa

Detalles Bibliográficos
Autores principales: Schweisberger, Cintya, Jacobson, Jill Diane, Paprocki, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089820/
http://dx.doi.org/10.1210/jendso/bvab048.1429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089820/
http://dx.doi.org/10.1210/jendso/bvab048.1429

Ejemplares similares